Target-Mediated Drug Disposition Revisited: Michaelis-Menten Approximations for Bivalent Drug Molecules

Area of Science:

• Pharmacokinetics and Pharmacodynamics
• Biopharmaceutical Sciences
• Computational Biology

Background:

• Monoclonal antibodies are bivalent, yet often modeled using Michaelis-Menten (MM) approximations.
• Target-mediated drug disposition (TMDD) models describe nonlinear drug behavior.
• Existing models may not fully capture the complexities of bivalent drug interactions.

Purpose of the Study:

• To analyze a TMDD model specifically for bivalent drugs.
• To provide a theoretical justification for using MM approximations in bivalent drug PK/PD.
• To investigate the influence of target avidity on model approximations.

Main Methods:

• Application of quasi-steady state approximations to a bivalent TMDD model.
• Analysis of model behavior under varying avidity conditions (weak and strong).
• Comparison of derived approximations with the standard MM model.

Main Results:

• The TMDD model for bivalent drugs yields MM approximations under specific avidity conditions.
• Weak avidity (soluble targets) leads to MM approximations.
• Strong avidity (cell surface targets) also results in MM approximations.
• Justification for MM approximations in bivalent drugs with slow systemic clearance.

Conclusions:

• The Michaelis-Menten approximation is a valid simplification for bivalent drugs in TMDD models.
• Avidity of the target (soluble vs. cell surface) dictates the conditions under which MM approximations hold.
• This work supports the continued use of MM approximations for bivalent antibody PK/PD analysis.